• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Methyl 2-acetamido-5- bromobenzoate (CAS No. 138825-96-4): A Comprehensive Overview in Modern Chemical Research

Methyl 2-acetamido-5-bromobenzoate, identified by its CAS number 138825-96-4, is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its brominated benzoate backbone with an acetamide substituent, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry and drug development. The presence of both the bromine atom and the acetamide group provides a versatile platform for further functionalization, enabling researchers to explore diverse molecular architectures.

The Methyl 2-acetamido-5-bromobenzoate molecule's structural features are particularly relevant in the context of medicinal chemistry. The bromine substituent at the 5-position of the benzoate ring enhances its reactivity, making it a suitable candidate for cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex heterocyclic systems, which are often found in biologically active molecules. Additionally, the acetamide group can serve as a pharmacophore or a site for further derivatization, contributing to the development of novel therapeutic agents.

In recent years, there has been growing interest in exploring the pharmacological potential of benzoate derivatives. The Methyl 2-acetamido-5-bromobenzoate compound has been investigated for its possible applications in modulating inflammatory pathways and enzymatic activities. Preliminary studies suggest that derivatives of this compound may exhibit anti-inflammatory properties by interacting with specific targets involved in the inflammatory cascade. For instance, modifications at the acetamide moiety could lead to enhanced binding affinity to enzymes such as cyclooxygenase (COX) or lipoxygenase (LOX), which are key players in inflammation.

The synthesis of Methyl 2-acetamido-5-bromobenzoate involves multi-step organic transformations that highlight the compound's synthetic utility. A common synthetic route begins with the bromination of 2-formylbenzoic acid, followed by condensation with ammonia or ammonium acetate to introduce the acetamide group. Subsequent esterification with methanol under acidic conditions yields the final product. This synthetic pathway is not only efficient but also scalable, making it suitable for industrial applications where large quantities of the compound are required for research or commercial purposes.

The chemical stability and reactivity of Methyl 2-acetamido-5-bromobenzoate are critical factors that influence its applicability in various chemical processes. The bromine atom enhances electrophilic aromatic substitution reactions, allowing for further functionalization at different positions on the benzoate ring. This flexibility is particularly useful in drug discovery pipelines, where precise control over molecular structure is essential for achieving desired biological activity. Additionally, the acetamide group can undergo hydrolysis or amidation reactions, providing additional pathways for structural diversification.

In academic research, Methyl 2-acetamido-5-bromobenzoate has been employed as a building block in the synthesis of more complex molecules. For example, researchers have utilized this compound to develop novel protease inhibitors by incorporating it into peptidomimetic structures. The bromine atom serves as a handle for introducing various substituents through palladium-catalyzed cross-coupling reactions, while the acetamide group can be modified to optimize binding interactions with target proteins. Such studies underscore the compound's importance in advancing our understanding of molecular recognition and drug design.

The role of computational chemistry in studying Methyl 2-acetamido-5-bromobenzoate cannot be overstated. Advanced computational methods such as density functional theory (DFT) and molecular dynamics (MD) simulations have enabled researchers to predict the compound's behavior under different conditions with high accuracy. These simulations help in understanding its electronic structure, reactivity patterns, and potential interactions with biological targets. Such insights are invaluable for guiding experimental work and optimizing synthetic strategies.

The future prospects of Methyl 2-acetamido-5-bromobenzoate in pharmaceutical research are promising. As our understanding of disease mechanisms continues to evolve, there is an increasing demand for innovative chemical entities that can modulate these pathways effectively. The unique structural features of this compound make it a compelling candidate for further exploration in areas such as oncology, neurology, and immunology. By leveraging its synthetic versatility and biological potential, researchers may uncover new therapeutic opportunities that could benefit patients worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)